Physician
Preventive Medicine
Dr. Bruce V. Stadel, MD
|
|
Give Review
Bruce Stadel is an expert in the field of Preventive Medicine. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a one of the best medicals schools. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine Bruce Stadel is a published physician. He published 57 publications, including: 'Estrogen therapy and endometrial carcinoma.'
Publications
- Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study.
- Hormone replacement therapy and risk of breast cancer.
- The relationship of tubal infertility to barrier method and oral contraceptive use.
- Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
- Efficacy of metformin in non-insulin-dependent diabetes mellitus.
- Risks and benefits of insulin-like growth factor.
- Estrogen replacement therapy in breast cancer survivors.
- Acute pancreatitis associated with growth hormone therapy for short stature.
- Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.
- Prepubertal gynecomastia during growth hormone therapy.
- Ectopic pregnancy and tubal ligation.
- Fatal myocardial infarction and the role of oral contraceptives.
- Variation of ethinylestradiol blood levels among healthy women using oral contraceptives.
- Intrauterine device usage and fetal loss.
- Cost of case-control studies.
- Risk factors for fatal heart attack in young women.
- Oral contraceptives and cardiovascular disease (second of two parts).
- Oral contraceptives and cardiovascular disease (first of two parts).
- Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use.
- Tubal infertility in relation to prior induced abortion.
- Tubal infertility and the intrauterine device.
- Primary tubal infertility in relation to the use of an intrauterine device.
- The relation of endometriosis to menstrual characteristics, smoking, and exercise.
- Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease.
- Exposure opportunity in epidemiologic studies.
- Appendectomy and the risk of tubal infertility.
- Consistency and plausibility in epidemiologic analysis: application to breast cancer in relation to use of oral contraceptives.
- Appendectomy and tubal infertility.
- Postcoital test abnormalities in relation to contraceptive use.
- Oral contraceptives and breast cancer.
- Oral contraceptives and breast cancer in young women.
- The future of automated record linkage for postmarketing surveillance: a response to Shapiro.
- Oral contraceptive use in women with a family history of breast cancer.
- A method of pharmacoepidemiologic analysis that uses computerized Medicaid.
- Trends in the content and use of oral contraceptives in the United States, 1964-88.
- Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease.
- Breast cancer detection in relation to oral contraception.
- Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine.
- The risk of epithelial ovarian cancer in short-term users of oral contraceptives.
- Letter: The etiology and prevention of ovarian cancer.
- Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973-2974.
- Estrogen therapy and endometrial carcinoma.
- Mycoplasma pneumoniae infection followed by Haemophilus influenzae pneumonia and bacteremia.
- Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia.
- Fibroadenoma in oral contraceptive users: a histopathologic evaluation of epithelial atypia.
- Dietary iodine and risk of breast, endometrial, and ovarian cancer.
- Letter: Thromboembolism, oral contraceptives, and oestrogen concentration gradient.
- Gabapentin for postherpetic neuralgia.
- Comparison of beclomethasone, salmeterol, and placebo in children with asthma.
- Lactic acidosis in patients with diabetes treated with metformin.
- Papilledema in 15 renally compromised patients treated with growth hormone.
- Breast cancer risk in relation to type of estrogen contained in oral contraceptives.
- Breast cancer in relation to early use of oral contraceptives. No evidence of a latent effect.
- Oral contraceptives and premenopausal breast cancer in nulliparous women.
- Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed.
- Misleading use of risk ratios.
Schools
University of California At Los Angeles
Los Angeles County University Of California Med Center
University Wash Hospital
Doctors Specialties
- Preventive Medicine
Accepted Insurances
Education
-
University of Washington School Public Health -
University of Southern California - LAC+USC Medical Center -
David Geffen School of Medicine at UCLA
Helpful Reviews
Similar Doctors
|
|
Anastasia T. Phantis-Gyftopoulo
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Y. Chin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth P. Moritsugu, MD
This Doctor is OpenDoctor Recommended.
|